Drug General Information (ID: DDII7SELBN)
  Drug Name Phenylpropanolamine Drug Info Alimemazine Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Appetite Depressants Antihistamines
  Structure

 Mechanism of Phenylpropanolamine-Alimemazine Interaction (Severity Level: Moderate)
     Antagonize the effect of dopaminergic agents Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Phenylpropanolamine Alimemazine
      Mechanism Dopaminergic effects
Dopamine receptor  Agonist
Antidopaminergic effects
Dopamine receptor  Antagonist
      Key Mechanism Factor 1
Factor Name Dopamine receptor Structure Sequence
Protein Family G-protein coupled receptor 1 family
Protein Function
Dopamine receptor whose activity is mediated by G proteins which activate adenylyl cyclase.
    Click to Show/Hide
      Mechanism Description
  • Antagonize the effect of Phenylpropanolamine when combined with Alimemazine 

Recommended Action
      Management Amphetamine, amphetamine derivatives, and other CNS stimulants should generally not be used, particularly for weight reduction, in patients treated with phenothiazines.

References
1 Lake CR "Manic psychosis after coffee and phenylpropanolamine." Biol Psychiatry 30 (1991): 401-4. [PMID: 1912131]
2 Markowitz JS, Patrick KS "Pharmacokinetic and pharmacodynamic drug interactions in the treatment of attention-deficit hyperactivity disorder." Clin Pharmacokinet 40 (2001): 753-72. [PMID: 11707061]
3 Reid AA "Pharmacological antagonism between chlorpromazine and phenmetrazine in mental hospital patients." Med J Aust 1 (1964): 187-8. [PMID: 14126355]